Press Release 2023 - Sami-Sabinsa Group | Formerly Known as Sami Labs Limited

Disclaimer

Please note that this website and information provided herein is not for final consumers of a finished food, beverage, dietary supplement product or cosmetic product, as the information contained herein does not refer to finished products for consumers.

The information provided on the website is intended only for producers of finished food, beverage, dietary supplement and cosmetic product.

The statements related to ingredients on the website, have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

The website and information herein are available in various countries across the world, and hence statements or product information including its classification may not be applicable in your country.

Information and statements provided on the website, shall not be construed as license to practice, or recommendations to infringe, any patents or other intellectual property rights of Sabinsa and others.

By browsing further, You understand the above terms.

Sami-Sabinsa Names Ahmed Khan VP Sales & Marketing North America

Sabinsa to Showcase Innovative Hair Care & Skin Care Actives at NYSCC 2023

Sami-Sabinsa Products Well-Received at incosmetics Global Expo 2023

Sabinsa to Showcase Curcumin C3 Reduct® and other Novel Ingredients at in-cosmetics Global Expo 2023

Sami-Sabinsa Reaches Intellectual Property Milestone with Over 400 Granted Patents

Clinical Study Published on Blood Sugar Support Benefits of Sami-Sabinsa’s Saberry® Standardized Amla Ingredient

Certificates

Global Offices

Get in Touch

Disclaimer